Small Bowel Obstruction Caused by Tubo-Ovarian Abscess Following Chronic Pelvic Inflammatory Disease: A Case Report

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher

Abstract

Abstract BackgroundAlthough there are reports of small bowel obstruction (SBO) secondary to tubo-ovarian abscess (TOA), there have been no documented cases of unexpected SBO, multiple intestinal ruptures and adhesions in a patient with chronic PID followed by successful surgical treatment of TOA who was successfully treated by surgery after failure by conservative treatment.Case presentationA 40-year-old female was admitted with main complaint of abdominal pain and fever for six days. A pelvic mass measuring 6.37x7.85x9.04 cm and ascites at rectovaginal pouch were found despite local treatment with metronidazole and cefazolin. Laboratory tests revealed leukocytosis of 8.9x10^9/L with hyper-neutrocytophilia of 82.8%, C-reactive protein increase at 223 mg/L and Procalcitonin 0.14ng/L. The patient was diagnosed with an acute attack of chronic PID. Tests and body temperature improved after 4 days of IV antibiotics. However, two days later, the patient presented abdominal distension, poor appetite, and difficulty in defecation. Abdominal CT suggested possibility of bowel obstruction. Accordingly, an explorative laparoscopy was performed, revealing 500ml pale yellow ascites within the abdominal cavity. The intestinal tube was clearly dilated with poor peristalsis. Multiple intestinal ruptures and adhesions were found. Dense adhesion existed between the intestinal loop and posterior uterus wall, closing the rectouterine pouch. Pale yellow thick pus could be seen from the end of fallopian tube, and part of the right ovary showed serious pyosis. All the adhesions were split, ruptures were repaired and normal anatomy was restored. Postoperative pathology indicated acute and chronic inflammation of both fallopian tubes with focal abscess formation. The patient was discharged 15 days after operation and followed up at one month without any symptoms.ConclusionIn such cases, close attention should be paid to changes in the patient’s condition and lesion changes. Early laparoscopy is advised when there are significant clinical or CT scan signs of bowel obstruction in TOA patients. Precise predictors or a predictive model for the need of invasive intervention to TOA will require further investigation.
Full text 47,724 characters · extracted from preprint-html · click to expand
Small Bowel Obstruction Caused by Tubo-Ovarian Abscess Following Chronic Pelvic Inflammatory Disease: A Case Report | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Case report Small Bowel Obstruction Caused by Tubo-Ovarian Abscess Following Chronic Pelvic Inflammatory Disease: A Case Report Yanan Li, Xiao Zhang, Yaxuan Zhao, Zhiqiang Zhang, Li Meng, Yanfang Du, and 1 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-625751/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Background Although there are reports of small bowel obstruction (SBO) secondary to tubo-ovarian abscess (TOA), there have been no documented cases of unexpected SBO, multiple intestinal ruptures and adhesions in a patient with chronic PID followed by successful surgical treatment of TOA who was successfully treated by surgery after failure by conservative treatment. Case presentation A 40-year-old female was admitted with main complaint of abdominal pain and fever for six days. A pelvic mass measuring 6.37x7.85x9.04 cm and ascites at rectovaginal pouch were found despite local treatment with metronidazole and cefazolin. Laboratory tests revealed leukocytosis of 8.9x10^9/L with hyper-neutrocytophilia of 82.8%, C-reactive protein increase at 223 mg/L and Procalcitonin 0.14ng/L. The patient was diagnosed with an acute attack of chronic PID. Tests and body temperature improved after 4 days of IV antibiotics. However, two days later, the patient presented abdominal distension, poor appetite, and difficulty in defecation. Abdominal CT suggested possibility of bowel obstruction. Accordingly, an explorative laparoscopy was performed, revealing 500ml pale yellow ascites within the abdominal cavity. The intestinal tube was clearly dilated with poor peristalsis. Multiple intestinal ruptures and adhesions were found. Dense adhesion existed between the intestinal loop and posterior uterus wall, closing the rectouterine pouch. Pale yellow thick pus could be seen from the end of fallopian tube, and part of the right ovary showed serious pyosis. All the adhesions were split, ruptures were repaired and normal anatomy was restored. Postoperative pathology indicated acute and chronic inflammation of both fallopian tubes with focal abscess formation. The patient was discharged 15 days after operation and followed up at one month without any symptoms. Conclusion In such cases, close attention should be paid to changes in the patient’s condition and lesion changes. Early laparoscopy is advised when there are significant clinical or CT scan signs of bowel obstruction in TOA patients. Precise predictors or a predictive model for the need of invasive intervention to TOA will require further investigation. Obstetrics & Gynecology Oncology small bowel obstruction pelvic inflammatory disease laparoscopy early intervention case report Figures Figure 1 Background Small bowel obstruction (SBO), a common clinical symptom, is defined as a blockage of gas and stool associated with incoercible vomiting. SBO continues to be a substantial cause of morbidity and mortality, accounting for 12–16% of hospital admissions for the evaluation of acute abdominal pain in the United States [ 1 ]. Studies have shown that the most common causes of SBO are intestinal adhesions, tumors, hernias, and inflammatory bowel disease, 10% of which may be further due to infection or inflammation (e.g. appendicitis, diverticulitis, endometriosis, pelvic inflammatory disease (PID), intestinal disease, abdominal tuberculosis), or chemical peritonitis and irritation caused by foreign bodies [ 2 , 3 ]. Thirty-three percent of SBO occur in the first year following the triggering factor [ 2 ]. Tubo-ovarian abscess (TOA), a complication of PID, can be severe and life-threatening. There is little in the literature about SBO secondary to acute TOA [ 3 , 4 ]. Herein, we report an educational case of unexpected SBO in a patient with chronic PID followed by TOA in whom multiple intestinal ruptures and adhesions were found that were successfully treated by surgery after conservative treatment failed. Case Presentation A 40-year-old female was admitted with main complaint of abdominal pain and fever for six days. A pelvic mass was found five days prior to admission despite local treatment with metronidazole and cefazolin. The G2P1A1 patient had regular menstruation, IUD for contraception, and cesarean Sect. 20 years prior. She suffered intermittent lower abdominal pain for six months without undergoing regular treatment. On abdominal physical examination, vital signs were normal and there was persistent abdominal distension and tenderness of the lower quadrant, radiating to her waist and iliac fossa. Discomfort followed palpation around the umbilicus. Both Murphy’s sign and McBurney’s sign were negative. Gynecological examination revealed vaginal swelling, redness, and thick curdy discharge. There was no tenderness on cervix and uterine body. A right adnexal mass could be palpated behind uterus with unclear boundaries, tenderness, adhesion to the uterus and poor movability. Laboratory tests revealed leukocytosis of 8.9x10^9/L with hyper-neutrocytophilia of 82.8%, C-reactive protein increase at 223 mg/L (normal values: 0.0–8.0 mg/l) and Procalcitonin (PCT) 0.14ng/L. Serum biochemistry and human chorionic gonadotropin were normal. Leucorrhea DNA was positive for candida and negative for trichomonas and Gardnerella. Gynecological ultrasonography suggested an inflammatory right pelvic mixed mass measuring 6.37x7.85x9.04 cm and ascites at rectovaginal pouch measuring 4.87x4.25x1.77cm. The patient was diagnosed with an acute attack of chronic PID. The patient received a vaginal clotrimazole tablet and IV administration of cefamandole and morinidazole for four days. Laboratory review revealed the following WBC count: 6.7x10^9/L, neutrophil percentage: 75.8%; Procalcitonin: 0.09ng/ml; C-reactive protein: 107.0mg/L. As tests and body temperature of patient improved, she continued to receive conservative treatment. Six days after initial treatment, the patient presented abdominal distension, poor appetite, and difficulty in defecation. Physical examination showed abdominal distension, lower abdominal tenderness, but normal borborygmus. Blood routine reexamination revealed WBC count: 9.6x10^9/L, neutrophil percentage: 83.0%; Procalcitonin: 0.06ng/ml; C-reactive protein: 35.8mg/L. Reexamination of gynecological ultrasonography indicated a liquid tubular mass with thick wall measuring 6.30x3.84x1.69cm posterior to uterus. Abdominal CT suggested possibility of bowel obstruction (Fig. 1 a). In light of the symptoms and imaging findings, an explorative laparoscopy was performed, revealing 500ml pale yellow ascites within the abdominal cavity. The intestinal tube was clearly dilated with poor peristalsis. Partial intestinal wall was congested with dark color (Fig. 1 b). The uterus retained a normal size and smooth anterior wall, but showed dense adhesion between intestinal loop and posterior wall, closing the rectouterine pouch and largely preventing exposure of bilateral adnexa (Fig. 1 c). During dissection, part of the intestinal tube was found to be attached to the posterior wall of the uterus and bilateral adnexa in the form of "W" loop adhesion, resulting in intestinal segment stenosis at the adhesion site and above intestinal obstruction. Pale yellow thick pus could be seen from the end of the tube, while fallopian tubes and part of the right ovary showed serious pyosis. Left ovary retained a normal appearance. Multiple intestinal ruptures were found after separation (Fig. 1 d). Subsequent exploration of the bowel was performed with a total revision from Treitz to rectum under laparotomy. The intestinal tube was observed to be black and weak at 1.3m from Treitz, with "W" shape adhesion at 1.7m, a rupture of 1cm in diameter at 2m and 2.1m adhesions, pelvic adhesions at 2.8m, and a hole of 2mm visible at 3.2m. No rupture was found in the appendix, sigmoid colon or rectum. All the adhesions were split, ruptures were repaired and normal anatomy was restored. Flushing out the contents of the small intestine into the colon reduced pressure in the small intestine. Abdominal cavity was fully flushed, and two "double cannula" drains were placed from the left and right lower abdomen, respectively. A mushroom-head drainage tube was placed in the anal canal. Postoperative pathology indicated acute and chronic inflammation of both fallopian tubes with focal abscess formation. The patient rapidly regained bowel movement and was given food and antibiotics (cefoperazone sodium sulbactam sodium 3g Q8h and morinidazole 0.5 g BID) for 14 days. Bacteriology analysis of ascites found E. coli. The patient was satisfied and discharged 15 days after operation and followed up at one month without any symptoms. Discussion And Conclusions PID comprises a spectrum of inflammatory disorders of the upper female genital tract, including any combination of endometritis, salpingitis, TOA, and pelvic peritonitis [ 5 ]. PID is difficult to diagnose because of the wide variation in symptoms and signs associated with this condition. Many women with PID have subtle or nonspecific symptoms or are asymptomatic. Pelvic inflammation involves the intestinal canal and appendix, leading to local edema, followed by fibrinous purulent exudate, and in turn, adhesion with surrounding organs. From a pathophysiological standpoint, it is well accepted that adhesions occur within seven days following the peritoneal injury, becoming progressively organized with fibrotic tissues. On average, patients must be readmitted twice over the subsequent 10 years due to such adhesions [ 2 , 6 ]. Acute PID primarily cause paralytic ileus, while recurrent chronic pelvic viscera adhesion mainly result in mechanical ileus [ 4 , 7 ]. Ultrasound scanning may be useful to confirm a pelvic abscess while computed tomography (CT) or magnetic resonance imaging (MRI) can help rule out other causes of peritonitis. The potential utility of MRI scanning of the pelvis in excluding differential diagnoses has been well established [ 8 ]. The choice and timing of surgery in PID is still controversial. Conservative management of PID with antibiotics alone remains first-line, with success rates of about 70% [ 5 , 8 , 9 ]. A five-year retrospective study aimed at investigating whether early surgical management improves outcomes in patients presenting with a TOA suggested that early surgery may be beneficial in the management of TOAs. Nineteen (38.0%) patients were treated with antibiotics (medical group) and thirty-one (62.0%) were treated surgically on admission (early surgical group). The early surgical group was associated with a high success rate of 96.8% and the lowest risk of readmission within 12 months (16.1%) [ 10 ]. A systematic review indicates that better outcomes in the management of TOA were achieved via a minimally invasive approach compared to conservative treatment with antibiotics only [ 11 ]. But how to predict the necessity for invasive intervention in TOA? Ribak et al. [ 12 ] evaluated 48 of 94 patients (51.1%) hospitalized with complicated PID who were sonographically diagnosed with TOA. They found that CRP was a sensitive, specific inflammatory marker for predicting TOA in patients with complicated PID, while levels > 49.3 mg/L suggested the presence of TOA. They concluded that increasing CRP levels may be used as a predictor for invasive intervention. Levin et al. [ 13 ] found that CA-125 level was the only independent factor associated with failure of conservative parenteral antibiotic therapy for TOA (OR; 95% confidence interval [CI], 1.27,1.08–1.48, p = 0.03). Moreover, abscesses larger than 10 clinepagem have greater than 60% chance of surgery in addition to antibiotics [ 11 ]. The size of TOA may be another predictor for the need of invasive intervention. In summary, PID is a rare cause of SBO. Close attention should be paid to changes in the patient’s condition and lesion changes. Early laparoscopy is advised when there are significant clinical or CT scan signs of bowel obstruction in PID patients. Precise predictors or a predictive model for the need of invasive intervention to TOA will require further investigation. Abbreviations SBO: Small bowel obstruction PID: pelvic inflammatory disease TOA: tubo-ovarian abscess PCT: procalcitonin Declarations Ethics approval and consent to participate Ethics approval was not required and the patient gave her written consent form to participate. In the form, the patient has given her consent for her images and other clinical information to be reported. The patient understands that her name and initials will not be published and due efforts will be made to conceal her identity, but anonymity cannot be guaranteed. Consent to publish Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal. Availability of data and materials The datasets used during the current study are available from the corresponding author on reasonable request. Competing interests The authors have no financial or non-financial competing interests to declare. Funding The authors have no sources of funding for the research reported to declare. Authors' contributions Z.Z., Y.Z., Y.X.Z. and L.M. managed the patient and participated in the surgery. Literature search and data analysis were performed by Y.L.. A first draft of the manuscript was written by X.Z. and was critically reviewed and edited by Y.L., and Y.D.. X.H. supervised the work. All authors read and approved the final manuscript. Acknowledgements Not applicable. Author information Affiliations Department of Obstetrics and Gynecology, the Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang 050000, China Yanan Li, Xiao Zhang, Zhiqiang Zhang, Yuan Zhang, Li Meng, Xianghua Huang & Yanfang Du Psychologic medicine of Basic Medical College, Hebei Medical College, 361 Zhongshan Road, Shijiazhuang 050000, China Yaxuan Zhao Corresponding author Correspondence to Yanfang Du. References Paulson EK, Thompson WM. Review of small-bowel obstruction: the diagnosis and when to worry. Radiology. 2015;275(2):332–42. Mazzetti CH, Serinaldi F, Lebrun E, Lemaitre J. Early laparoscopic adhesiolysis for small bowel obstruction: retrospective study of main advantages. Surgical endoscopy. 2018;32(6):2781–92. Haumann A, Ongaro S, Detry O, Meunier P, Meurisse M. Acute pelvic inflammatory disease as a rare cause of acute small bowel obstruction. Acta chirurgica Belgica. 2019;119(5):328–30. Al-Ghassab RA, Tanveer S, Al-Lababidi NH, Zakaria HM, Al-Mulhim AA. Adhesive Small Bowel Obstruction due to Pelvic Inflammatory Disease: A Case Report. Saudi journal of medicine medical sciences. 2018;6(1):40–2. Workowski KA, Bolan GA: Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports 2015;64(Rr-03): 1-137. Yao S, Tanaka E, Ikeda A, Murakami T, Okumoto T, Harada T. Outcomes of laparoscopic management of acute small bowel obstruction: a 7-year experience of 110 consecutive cases with various etiologies. Surg Today. 2017;47(4):432–9. Weledji EP. Perspectives on paralytic ileus. Acute medicine surgery. 2020;7(1):e573. Ross J, Guaschino S, Cusini M, Jensen J. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS. 2018;29(2):108–14. Cooperative, Group, of, Infectious, Disease, Chinese, et al.: [Guideline of pelvic inflammatory disease (2019 revised edition)]. Zhonghua fu chan ke za zhi 2019;54(7): 433–437. Zhu S, Ballard E, Khalil A, Baartz D, Amoako A, Tanaka K. Impact of early surgical management on tubo-ovarian abscesses. Journal of obstetrics and gynaecology: the journal of the Institute of Obstetrics and Gynaecology 2020: 1–5. Goje O, Markwei M, Kollikonda S, Chavan M, Soper DE: Outcomes of Minimally Invasive Management of Tubo-ovarian Abscess: A Systematic Review. Journal of minimally invasive gynecology 2020. Ribak R, Schonman R, Sharvit M, Schreiber H, Raviv O, Klein Z. Can the Need for Invasive Intervention in Tubo-ovarian Abscess Be Predicted? The Implication of C-reactive Protein Measurements. J Minim Invasive Gynecol. 2020;27(2):541–7. Levin G, Herzberg S, Dior UP, Shushan A, Gilad R, Benshushan A, et al. The predictive role of CA-125 in the management of tubo-ovarian abscess. A retrospective study. Eur J Obstet Gynecol Reprod Biol. 2019;238:20–4. Supplementary Files CAREchecklistEnglish2013.pdf Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-625751","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Case report","associatedPublications":[],"authors":[{"id":37171299,"identity":"5e031b26-49c3-45a8-aa78-44e4b704fec0","order_by":0,"name":"Yanan Li","email":"","orcid":"","institution":"Second Hospital of Hebei Medical University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Yanan","middleName":"","lastName":"Li","suffix":""},{"id":37171300,"identity":"9f186fc8-6aa2-4b69-ab4e-d7f01bada85a","order_by":1,"name":"Xiao Zhang","email":"","orcid":"","institution":"Second Hospital of Hebei Medical University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Xiao","middleName":"","lastName":"Zhang","suffix":""},{"id":37171301,"identity":"922c8442-1a0e-46e0-be0e-f814a6e3ee78","order_by":2,"name":"Yaxuan Zhao","email":"","orcid":"","institution":"Hebei Medical University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Yaxuan","middleName":"","lastName":"Zhao","suffix":""},{"id":37171302,"identity":"7769d94e-938c-4a77-a295-758fd2003da9","order_by":3,"name":"Zhiqiang Zhang","email":"","orcid":"","institution":"Second Hospital of Hebei Medical University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Zhiqiang","middleName":"","lastName":"Zhang","suffix":""},{"id":37171303,"identity":"d262e58c-578b-4cb6-82dd-e7b0e1b8a277","order_by":4,"name":"Li Meng","email":"","orcid":"","institution":"Second Hospital of Hebei Medical University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Li","middleName":"","lastName":"Meng","suffix":""},{"id":37171304,"identity":"d217d53d-306f-44f6-92ff-5ea28b51edd9","order_by":5,"name":"Yanfang Du","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA/UlEQVRIiWNgGAWjYDCCAyDCBoiZmY///FAhISdPnJY0IGZnS5CWOGNhbNhAtBZ+HgMJ3raKRIgIHsB3I8fwc0GCXZ68M4+BgeQ8iQTGBuaHj27g0SJ5I8dYekZCcrHhYbaChMJtEnnsDGzGxjl4tBjcyDGQ5v3BnLixmXnDAcltEsWMDTxs0gS0GP/mSagHamEwbOCdI5HYcICwFjNpnoTDifOZWYwZeBuI0CJ55lmZNU/C8cQNzGxpzBLHJIwNmwn4he948ubbPAnVifP7Dx9j/FBTJyfP3vzwMT4tDAwcBhAXHoAJMONVDgLsD8CUfANBlaNgFIyCUTBSAQB1lEsdYg520gAAAABJRU5ErkJggg==","orcid":"https://orcid.org/0000-0002-2804-0982","institution":"the Second Hospital of Hebei Medical University","correspondingAuthor":true,"submittingAuthor":false,"prefix":"","firstName":"Yanfang","middleName":"","lastName":"Du","suffix":""},{"id":37171305,"identity":"9d7b7e2a-64ef-4b0a-9e67-c3ea615de163","order_by":6,"name":"Xianghua Huang","email":"","orcid":"","institution":"Second Hospital of Hebei Medical University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Xianghua","middleName":"","lastName":"Huang","suffix":""}],"badges":[],"createdAt":"2021-06-16 01:59:50","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-625751/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-625751/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":11225408,"identity":"4aabc29f-ec67-4ff1-aca2-9326e47a29a6","added_by":"auto","created_at":"2021-07-07 19:33:06","extension":"png","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":2078707,"visible":true,"origin":"","legend":"a:Computed tomography (frontal section) showing edema and diffuse in exudation mesentery, intestinal tube and abdominal wall, multiple gas shadows and increased density in the ascending colon of the right lower abdomen. b: Obvious intestinal distension, poor peristalsis, partial intestinal wall congestion, and multiple adhesions could be seen. c: The posterior wall of the uterus adhered tightly to the intestinal loop, sealing the pelvic cavity behind the uterus. Bilateral attachments cannot be exposed. d: A ruptured bowel. ","description":"","filename":"1.png","url":"https://assets-eu.researchsquare.com/files/rs-625751/v1/95dcbed13ee6445c82cda7d1.png"},{"id":13702815,"identity":"29b62b61-f46c-44db-8d85-49f3d0a73789","added_by":"auto","created_at":"2021-09-17 13:37:39","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":3003080,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-625751/v1/e50b4133-c206-4593-9fe9-ce5da86ab3c5.pdf"},{"id":11225409,"identity":"c0e09d9c-1cd4-4464-b5da-284942c1eba0","added_by":"auto","created_at":"2021-07-07 19:33:06","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":755630,"visible":true,"origin":"","legend":"","description":"","filename":"CAREchecklistEnglish2013.pdf","url":"https://assets-eu.researchsquare.com/files/rs-625751/v1/69b0530034f53fcecbe7a15c.pdf"}],"financialInterests":"","formattedTitle":"\u003cp\u003eSmall Bowel Obstruction Caused by Tubo-Ovarian Abscess Following Chronic Pelvic Inflammatory Disease: A Case Report\u003c/p\u003e","fulltext":[{"header":"Background","content":" \u003cp\u003eSmall bowel obstruction (SBO), a common clinical symptom, is defined as a blockage of gas and stool associated with incoercible vomiting. SBO continues to be a substantial cause of morbidity and mortality, accounting for 12\u0026ndash;16% of hospital admissions for the evaluation of acute abdominal pain in the United States [\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e]. Studies have shown that the most common causes of SBO are intestinal adhesions, tumors, hernias, and inflammatory bowel disease, 10% of which may be further due to infection or inflammation (e.g. appendicitis, diverticulitis, endometriosis, pelvic inflammatory disease (PID), intestinal disease, abdominal tuberculosis), or chemical peritonitis and irritation caused by foreign bodies [\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e, \u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e]. Thirty-three percent of SBO occur in the first year following the triggering factor [\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e]. Tubo-ovarian abscess (TOA), a complication of PID, can be severe and life-threatening. There is little in the literature about SBO secondary to acute TOA [\u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e, \u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e]. Herein, we report an educational case of unexpected SBO in a patient with chronic PID followed by TOA in whom multiple intestinal ruptures and adhesions were found that were successfully treated by surgery after conservative treatment failed.\u003c/p\u003e "},{"header":"Case Presentation","content":" \u003cp\u003eA 40-year-old female was admitted with main complaint of abdominal pain and fever for six days. A pelvic mass was found five days prior to admission despite local treatment with metronidazole and cefazolin. The G2P1A1 patient had regular menstruation, IUD for contraception, and cesarean Sect.\u0026nbsp;20 years prior. She suffered intermittent lower abdominal pain for six months without undergoing regular treatment.\u003c/p\u003e \u003cp\u003eOn abdominal physical examination, vital signs were normal and there was persistent abdominal distension and tenderness of the lower quadrant, radiating to her waist and iliac fossa. Discomfort followed palpation around the umbilicus. Both Murphy\u0026rsquo;s sign and McBurney\u0026rsquo;s sign were negative. Gynecological examination revealed vaginal swelling, redness, and thick curdy discharge. There was no tenderness on cervix and uterine body. A right adnexal mass could be palpated behind uterus with unclear boundaries, tenderness, adhesion to the uterus and poor movability.\u003c/p\u003e \u003cp\u003eLaboratory tests revealed leukocytosis of 8.9x10^9/L with hyper-neutrocytophilia of 82.8%, C-reactive protein increase at 223 mg/L (normal values: 0.0\u0026ndash;8.0 mg/l) and Procalcitonin (PCT) 0.14ng/L. Serum biochemistry and human chorionic gonadotropin were normal. Leucorrhea DNA was positive for candida and negative for trichomonas and Gardnerella. Gynecological ultrasonography suggested an inflammatory right pelvic mixed mass measuring 6.37x7.85x9.04 cm and ascites at rectovaginal pouch measuring 4.87x4.25x1.77cm. The patient was diagnosed with an acute attack of chronic PID.\u003c/p\u003e \u003cp\u003eThe patient received a vaginal clotrimazole tablet and IV administration of cefamandole and morinidazole for four days. Laboratory review revealed the following WBC count: 6.7x10^9/L, neutrophil percentage: 75.8%; Procalcitonin: 0.09ng/ml; C-reactive protein: 107.0mg/L. As tests and body temperature of patient improved, she continued to receive conservative treatment. Six days after initial treatment, the patient presented abdominal distension, poor appetite, and difficulty in defecation. Physical examination showed abdominal distension, lower abdominal tenderness, but normal borborygmus. Blood routine reexamination revealed WBC count: 9.6x10^9/L, neutrophil percentage: 83.0%; Procalcitonin: 0.06ng/ml; C-reactive protein: 35.8mg/L.\u003c/p\u003e \u003cp\u003eReexamination of gynecological ultrasonography indicated a liquid tubular mass with thick wall measuring 6.30x3.84x1.69cm posterior to uterus. Abdominal CT suggested possibility of bowel obstruction (Fig.\u0026nbsp;\u003cspan refid=\"Fig1\" class=\"InternalRef\"\u003e1\u003c/span\u003ea). In light of the symptoms and imaging findings, an explorative laparoscopy was performed, revealing 500ml pale yellow ascites within the abdominal cavity. The intestinal tube was clearly dilated with poor peristalsis. Partial intestinal wall was congested with dark color (Fig.\u0026nbsp;\u003cspan refid=\"Fig1\" class=\"InternalRef\"\u003e1\u003c/span\u003eb). The uterus retained a normal size and smooth anterior wall, but showed dense adhesion between intestinal loop and posterior wall, closing the rectouterine pouch and largely preventing exposure of bilateral adnexa (Fig.\u0026nbsp;\u003cspan refid=\"Fig1\" class=\"InternalRef\"\u003e1\u003c/span\u003ec). During dissection, part of the intestinal tube was found to be attached to the posterior wall of the uterus and bilateral adnexa in the form of \"W\" loop adhesion, resulting in intestinal segment stenosis at the adhesion site and above intestinal obstruction. Pale yellow thick pus could be seen from the end of the tube, while fallopian tubes and part of the right ovary showed serious pyosis. Left ovary retained a normal appearance. Multiple intestinal ruptures were found after separation (Fig.\u0026nbsp;\u003cspan refid=\"Fig1\" class=\"InternalRef\"\u003e1\u003c/span\u003ed).\u003c/p\u003e \u003cp\u003eSubsequent exploration of the bowel was performed with a total revision from Treitz to rectum under laparotomy. The intestinal tube was observed to be black and weak at 1.3m from Treitz, with \"W\" shape adhesion at 1.7m, a rupture of 1cm in diameter at 2m and 2.1m adhesions, pelvic adhesions at 2.8m, and a hole of 2mm visible at 3.2m. No rupture was found in the appendix, sigmoid colon or rectum. All the adhesions were split, ruptures were repaired and normal anatomy was restored. Flushing out the contents of the small intestine into the colon reduced pressure in the small intestine. Abdominal cavity was fully flushed, and two \"double cannula\" drains were placed from the left and right lower abdomen, respectively. A mushroom-head drainage tube was placed in the anal canal.\u003c/p\u003e \u003cp\u003ePostoperative pathology indicated acute and chronic inflammation of both fallopian tubes with focal abscess formation. The patient rapidly regained bowel movement and was given food and antibiotics (cefoperazone sodium sulbactam sodium 3g Q8h and morinidazole 0.5 g BID) for 14 days. Bacteriology analysis of ascites found E. coli. The patient was satisfied and discharged 15 days after operation and followed up at one month without any symptoms.\u003c/p\u003e "},{"header":"Discussion And Conclusions","content":" \u003cp\u003ePID comprises a spectrum of inflammatory disorders of the upper female genital tract, including any combination of endometritis, salpingitis, TOA, and pelvic peritonitis [\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e]. PID is difficult to diagnose because of the wide variation in symptoms and signs associated with this condition. Many women with PID have subtle or nonspecific symptoms or are asymptomatic. Pelvic inflammation involves the intestinal canal and appendix, leading to local edema, followed by fibrinous purulent exudate, and in turn, adhesion with surrounding organs. From a pathophysiological standpoint, it is well accepted that adhesions occur within seven days following the peritoneal injury, becoming progressively organized with fibrotic tissues. On average, patients must be readmitted twice over the subsequent 10 years due to such adhesions [\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e, \u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e]. Acute PID primarily cause paralytic ileus, while recurrent chronic pelvic viscera adhesion mainly result in mechanical ileus [\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e, \u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eUltrasound scanning may be useful to confirm a pelvic abscess while computed tomography (CT) or magnetic resonance imaging (MRI) can help rule out other causes of peritonitis. The potential utility of MRI scanning of the pelvis in excluding differential diagnoses has been well established [\u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eThe choice and timing of surgery in PID is still controversial. Conservative management of PID with antibiotics alone remains first-line, with success rates of about 70% [\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e, \u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e, \u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e]. A five-year retrospective study aimed at investigating whether early surgical management improves outcomes in patients presenting with a TOA suggested that early surgery may be beneficial in the management of TOAs. Nineteen (38.0%) patients were treated with antibiotics (medical group) and thirty-one (62.0%) were treated surgically on admission (early surgical group). The early surgical group was associated with a high success rate of 96.8% and the lowest risk of readmission within 12 months (16.1%) [\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e]. A systematic review indicates that better outcomes in the management of TOA were achieved via a minimally invasive approach compared to conservative treatment with antibiotics only [\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e]. But how to predict the necessity for invasive intervention in TOA? Ribak et al. [\u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e12\u003c/span\u003e] evaluated 48 of 94 patients (51.1%) hospitalized with complicated PID who were sonographically diagnosed with TOA. They found that CRP was a sensitive, specific inflammatory marker for predicting TOA in patients with complicated PID, while levels\u0026thinsp;\u0026gt;\u0026thinsp;49.3 mg/L suggested the presence of TOA. They concluded that increasing CRP levels may be used as a predictor for invasive intervention. Levin et al. [\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e] found that CA-125 level was the only independent factor associated with failure of conservative parenteral antibiotic therapy for TOA (OR; 95% confidence interval [CI], 1.27,1.08\u0026ndash;1.48, p\u0026thinsp;=\u0026thinsp;0.03). Moreover, abscesses larger than 10 clinepagem have greater than 60% chance of surgery in addition to antibiotics [\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e]. The size of TOA may be another predictor for the need of invasive intervention.\u003c/p\u003e \u003cp\u003eIn summary, PID is a rare cause of SBO. Close attention should be paid to changes in the patient\u0026rsquo;s condition and lesion changes. Early laparoscopy is advised when there are significant clinical or CT scan signs of bowel obstruction in PID patients. Precise predictors or a predictive model for the need of invasive intervention to TOA will require further investigation.\u003c/p\u003e "},{"header":"Abbreviations","content":"\u003cp\u003e\u003cstrong\u003e\u003cem\u003eSBO:\u0026nbsp;\u003c/em\u003e\u003c/strong\u003eSmall bowel obstruction\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003ePID:\u003c/em\u003e\u003c/strong\u003e pelvic inflammatory disease\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003eTOA:\u0026nbsp;\u003c/em\u003e\u003c/strong\u003etubo-ovarian abscess\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003ePCT:\u0026nbsp;\u003c/em\u003e\u003c/strong\u003eprocalcitonin\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eEthics approval and consent to participate\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eEthics approval was not required and the patient gave her written consent form to participate. In the form, the patient has given her consent for her images and other clinical information to be reported. The patient understands that her name and initials will not be published and due efforts will be made to conceal her identity, but anonymity cannot be guaranteed.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConsent to publish\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eWritten informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAvailability of data and materials\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe datasets used during the current study are available from the corresponding author on reasonable request.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompeting interests\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe authors have no financial or non-financial competing interests to declare.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFunding\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe authors have no sources of funding for the research reported to declare.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthors\u0026apos; contributions\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eZ.Z., Y.Z., Y.X.Z. and L.M. managed the patient and participated in the surgery. Literature search and data analysis were performed by Y.L.. A first draft of the manuscript was written by X.Z. and was critically reviewed and edited by Y.L., and Y.D.. X.H. supervised the work. All authors read and approved the final manuscript.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAcknowledgements\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eNot applicable.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthor information\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eAffiliations\u003c/p\u003e\n\u003cp\u003eDepartment of Obstetrics and Gynecology, the Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang 050000, China\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eYanan Li, Xiao Zhang, Zhiqiang Zhang, Yuan Zhang, Li Meng, Xianghua Huang \u0026amp; Yanfang Du\u003c/p\u003e\n\u003cp\u003ePsychologic medicine of Basic Medical College, Hebei Medical College, 361 Zhongshan Road, Shijiazhuang 050000, China\u003c/p\u003e\n\u003cp\u003eYaxuan Zhao\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCorresponding author\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eCorrespondence to Yanfang Du.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\u003cli\u003e\u003cspan\u003ePaulson EK, Thompson WM. Review of small-bowel obstruction: the diagnosis and when to worry. Radiology. 2015;275(2):332\u0026ndash;42.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMazzetti CH, Serinaldi F, Lebrun E, Lemaitre J. Early laparoscopic adhesiolysis for small bowel obstruction: retrospective study of main advantages. Surgical endoscopy. 2018;32(6):2781\u0026ndash;92.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHaumann A, Ongaro S, Detry O, Meunier P, Meurisse M. Acute pelvic inflammatory disease as a rare cause of acute small bowel obstruction. Acta chirurgica Belgica. 2019;119(5):328\u0026ndash;30.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eAl-Ghassab RA, Tanveer S, Al-Lababidi NH, Zakaria HM, Al-Mulhim AA. Adhesive Small Bowel Obstruction due to Pelvic Inflammatory Disease: A Case Report. Saudi journal of medicine medical sciences. 2018;6(1):40\u0026ndash;2.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWorkowski KA, Bolan GA: Sexually transmitted diseases treatment guidelines, 2015. \u003cem\u003eMMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports\u003c/em\u003e 2015;64(Rr-03): 1-137.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eYao S, Tanaka E, Ikeda A, Murakami T, Okumoto T, Harada T. Outcomes of laparoscopic management of acute small bowel obstruction: a 7-year experience of 110 consecutive cases with various etiologies. Surg Today. 2017;47(4):432\u0026ndash;9.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWeledji EP. Perspectives on paralytic ileus. Acute medicine surgery. 2020;7(1):e573.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eRoss J, Guaschino S, Cusini M, Jensen J. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS. 2018;29(2):108\u0026ndash;14.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCooperative, Group, of, Infectious, Disease, Chinese, et al.: [Guideline of pelvic inflammatory disease (2019 revised edition)]. \u003cem\u003eZhonghua fu chan ke za zhi\u003c/em\u003e 2019;54(7): 433\u0026ndash;437.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eZhu S, Ballard E, Khalil A, Baartz D, Amoako A, Tanaka K. Impact of early surgical management on tubo-ovarian abscesses. \u003cem\u003eJournal of obstetrics and gynaecology: the journal of the Institute of Obstetrics and Gynaecology\u003c/em\u003e 2020: 1\u0026ndash;5.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGoje O, Markwei M, Kollikonda S, Chavan M, Soper DE: Outcomes of Minimally Invasive Management of Tubo-ovarian Abscess: A Systematic Review. \u003cem\u003eJournal of minimally invasive gynecology\u003c/em\u003e 2020.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eRibak R, Schonman R, Sharvit M, Schreiber H, Raviv O, Klein Z. Can the Need for Invasive Intervention in Tubo-ovarian Abscess Be Predicted? The Implication of C-reactive Protein Measurements. J Minim Invasive Gynecol. 2020;27(2):541\u0026ndash;7.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLevin G, Herzberg S, Dior UP, Shushan A, Gilad R, Benshushan A, et al. The predictive role of CA-125 in the management of tubo-ovarian abscess. A retrospective study. Eur J Obstet Gynecol Reprod Biol. 2019;238:20\u0026ndash;4.\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"small bowel obstruction, pelvic inflammatory disease, laparoscopy, early intervention, case report ","lastPublishedDoi":"10.21203/rs.3.rs-625751/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-625751/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003eBackground\u003c/strong\u003e\u003c/p\u003e\u003cp\u003eAlthough there are reports of small bowel obstruction (SBO) secondary to tubo-ovarian abscess (TOA), there have been no documented cases of unexpected SBO, multiple intestinal ruptures and adhesions in a patient with chronic PID followed by successful surgical treatment of TOA who was successfully treated by surgery after failure by conservative treatment.\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eCase presentation\u003c/strong\u003e\u003c/p\u003e\u003cp\u003eA 40-year-old female was admitted with main complaint of abdominal pain and fever for six days. A pelvic mass measuring 6.37x7.85x9.04 cm and ascites at rectovaginal pouch were found despite local treatment with metronidazole and cefazolin. Laboratory tests revealed leukocytosis of 8.9x10^9/L with hyper-neutrocytophilia of 82.8%, C-reactive protein increase at 223 mg/L and Procalcitonin 0.14ng/L. The patient was diagnosed with an acute attack of chronic PID. Tests and body temperature improved after 4 days of IV antibiotics. However, two days later, the patient presented abdominal distension, poor appetite, and difficulty in defecation. Abdominal CT suggested possibility of bowel obstruction. Accordingly, an explorative laparoscopy was performed, revealing 500ml pale yellow ascites within the abdominal cavity. The intestinal tube was clearly dilated with poor peristalsis. Multiple intestinal ruptures and adhesions were found. Dense adhesion existed between the intestinal loop and posterior uterus wall, closing the rectouterine pouch. Pale yellow thick pus could be seen from the end of fallopian tube, and part of the right ovary showed serious pyosis. All the adhesions were split, ruptures were repaired and normal anatomy was restored. Postoperative pathology indicated acute and chronic inflammation of both fallopian tubes with focal abscess formation. The patient was discharged 15 days after operation and followed up at one month without any symptoms.\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eConclusion\u003c/strong\u003e\u003c/p\u003e\u003cp\u003eIn such cases, close attention should be paid to changes in the patient’s condition and lesion changes. Early laparoscopy is advised when there are significant clinical or CT scan signs of bowel obstruction in TOA patients. Precise predictors or a predictive model for the need of invasive intervention to TOA will require further investigation.\u003c/p\u003e","manuscriptTitle":"Small Bowel Obstruction Caused by Tubo-Ovarian Abscess Following Chronic Pelvic Inflammatory Disease: A Case Report","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2021-07-07 19:33:04","doi":"10.21203/rs.3.rs-625751/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"ba75eab0-1f6d-42bb-882c-f7a34196ca1a","owner":[],"postedDate":"July 7th, 2021","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":5467517,"name":"Obstetrics \u0026 Gynecology"},{"id":5467518,"name":"Oncology"}],"tags":[],"updatedAt":"2021-07-07T19:33:06+00:00","versionOfRecord":[],"versionCreatedAt":"2021-07-07 19:33:04","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-625751","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-625751","identity":"rs-625751","version":["v1"]},"buildId":"ehx78VzkSd0WSzXnipQa-","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-25T06:39:03.707998+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC